X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with Divis Laboratories - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs DIVIS LABORATORIES - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE DIVIS LABORATORIES CADILA HEALTHCARE/
DIVIS LABORATORIES
 
P/E (TTM) x 35.2 18.1 193.8% View Chart
P/BV x 9.1 3.9 230.7% View Chart
Dividend Yield % 0.7 1.6 42.9%  

Financials

 CADILA HEALTHCARE   DIVIS LABORATORIES
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-16
DIVIS LABORATORIES
Mar-16
CADILA HEALTHCARE/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs4542,484 18.3%   
Low Rs305918 33.2%   
Sales per share (Unadj.) Rs96.1142.3 67.6%  
Earnings per share (Unadj.) Rs14.941.9 35.5%  
Cash flow per share (Unadj.) Rs17.846.3 38.5%  
Dividends per share (Unadj.) Rs3.2010.00 32.0%  
Dividend yield (eoy) %0.80.6 143.4%  
Book value per share (Unadj.) Rs52.3161.5 32.4%  
Shares outstanding (eoy) m1,023.74265.47 385.6%   
Bonus/Rights/Conversions FV5:1--  
Price / Sales ratio x3.912.0 33.0%   
Avg P/E ratio x25.540.6 62.8%  
P/CF ratio (eoy) x21.336.7 58.0%  
Price / Book Value ratio x7.310.5 68.9%  
Dividend payout %21.523.9 90.1%   
Avg Mkt Cap Rs m388,458451,525 86.0%   
No. of employees `00015.43.7 416.4%   
Total wages/salary Rs m13,3173,649 364.9%   
Avg. sales/employee Rs Th6,371.110,184.4 62.6%   
Avg. wages/employee Rs Th862.4984.1 87.6%   
Avg. net profit/employee Rs Th986.12,998.5 32.9%   
INCOME DATA
Net Sales Rs m98,37637,764 260.5%  
Other income Rs m941848 110.9%   
Total revenues Rs m99,31738,612 257.2%   
Gross profit Rs m23,82914,138 168.6%  
Depreciation Rs m3,0221,182 255.7%   
Interest Rs m48623 2,094.8%   
Profit before tax Rs m21,26213,781 154.3%   
Minority Interest Rs m-3000-   
Prior Period Items Rs m50-   
Extraordinary Inc (Exp) Rs m-250-   
Tax Rs m5,7162,662 214.7%   
Profit after tax Rs m15,22611,119 136.9%  
Gross profit margin %24.237.4 64.7%  
Effective tax rate %26.919.3 139.2%   
Net profit margin %15.529.4 52.6%  
BALANCE SHEET DATA
Current assets Rs m44,37630,947 143.4%   
Current liabilities Rs m34,0715,195 655.8%   
Net working cap to sales %10.568.2 15.4%  
Current ratio x1.36.0 21.9%  
Inventory Days Days54117 46.1%  
Debtors Days Days6285 73.2%  
Net fixed assets Rs m47,89617,027 281.3%   
Share capital Rs m1,024531 192.9%   
"Free" reserves Rs m48,74642,341 115.1%   
Net worth Rs m53,51942,877 124.8%   
Long term debt Rs m8,9645 190,723.4%   
Total assets Rs m100,16349,684 201.6%  
Interest coverage x44.7595.0 7.5%   
Debt to equity ratio x0.20 152,799.0%  
Sales to assets ratio x1.00.8 129.2%   
Return on assets %15.722.4 70.0%  
Return on equity %28.425.9 109.7%  
Return on capital %34.332.2 106.5%  
Exports to sales %45.385.3 53.1%   
Imports to sales %5.922.9 25.9%   
Exports (fob) Rs m44,53732,198 138.3%   
Imports (cif) Rs m5,8388,654 67.5%   
Fx inflow Rs m44,88132,270 139.1%   
Fx outflow Rs m9,0698,775 103.4%   
Net fx Rs m35,81223,496 152.4%   
CASH FLOW
From Operations Rs m19,93810,379 192.1%  
From Investments Rs m-9,039-4,135 218.6%  
From Financial Activity Rs m-9,527-6,241 152.6%  
Net Cashflow Rs m1,3723 41,575.8%  

Share Holding

Indian Promoters % 74.8 52.0 143.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 11.8 70.3%  
FIIs % 5.9 19.0 31.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 17.2 64.0%  
Shareholders   44,069 31,796 138.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   SUN PHARMA  DR. REDDYS LAB  GSK PHARMA  UNICHEM LAB  MERCK LTD  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Aug 18, 2017 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS